Golden Sun Health Technology Group Limited
GSUN
$2.23
-$0.11-4.70%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 65.04% | 24.11% | -11.19% | -30.40% | -43.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.04% | 24.11% | -11.19% | -30.40% | -43.08% |
| Cost of Revenue | 78.68% | 27.09% | -17.59% | -22.88% | -27.32% |
| Gross Profit | 31.82% | 16.91% | 4.16% | -42.44% | -62.75% |
| SG&A Expenses | -37.89% | -37.55% | -37.25% | -11.02% | 24.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.49% | -14.19% | -30.03% | -16.04% | -0.50% |
| Operating Income | 58.24% | 54.20% | 50.44% | -15.69% | -298.44% |
| Income Before Tax | 30.00% | 33.94% | 37.57% | -20.08% | -219.95% |
| Income Tax Expenses | -86.40% | -40.81% | 72.99% | -43.43% | -61.42% |
| Earnings from Continuing Operations | 31.34% | 34.05% | 36.59% | -16.94% | -172.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4,206.25% | 1,707.14% | 75.86% | 1,463.64% | 69.52% |
| Net Income | 35.95% | 36.50% | 37.02% | -16.56% | -170.47% |
| EBIT | 58.24% | 54.20% | 50.44% | -15.69% | -298.44% |
| EBITDA | 58.72% | 54.78% | 51.10% | -17.14% | -336.59% |
| EPS Basic | 39.48% | 41.73% | 43.69% | -4.98% | -137.37% |
| Normalized Basic EPS | 54.48% | 49.70% | 45.60% | -8.41% | -193.72% |
| EPS Diluted | 39.48% | 41.73% | 43.69% | -4.98% | -137.37% |
| Normalized Diluted EPS | 54.48% | 49.70% | 45.60% | -8.41% | -193.72% |
| Average Basic Shares Outstanding | 5.36% | 9.07% | 13.13% | 20.95% | 30.27% |
| Average Diluted Shares Outstanding | 5.36% | 9.07% | 13.13% | 20.95% | 30.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |